GDP for APIs

4-5 December 2018, Berlin, Germany

Course No. 16478



Fred Bauer, Boehringer Ingelheim Pharma GmbH & Co. KG, Germany

Dr Rainer Gnibl, EU-GMP Inspector, Local Government

Karl Metzger, gmPlan, Germany

Dr Volkmar Schimming, VS Consulting, Germany


This course is intended to provide guidance on the provisions laid down in the EU GDP guidelines for APIs. You will get to know the key aspects of these guidelines and you will learn about

  • What has to be considered regarding GDP-compliant storage and transportation of APIs
  • How the exchange of information between agents, traders and pharmaceutical manufacturers should work
  • Which risk assessment approaches are suitable and should be applied
  • What authorities expect regarding GDP-compliant storage, transportation and distribution of APIs


In March 2015, the “Guidelines on principles of Good Distribution Practice of active substances for medicinal products for human use” were published in the Official Journal of the European Union.

Since September 2015, the provisions of these Guidelines have been obligatory. The driving force behind these Guidelines is the combat against falsified drug substances and drug products. It is intended to control the entire supply chain and thus to mitigate the risk associated with complex distribution pathways. From now on, distributors are required e.g. to have a complete deviation management in place and to maintain a change management system as well as a CAPA system based on risk assessments. Moreover, a GMP-compliant complaint and recall management has to be established and a well trained staff has to ensure that all the requirements of the guidelines are met. In several sections of the Guidelines, it is pointed out that a thorough training of the employees is important.

Target Group

This education course is designed for all persons from companies involved in the distribution and supply of pharmaceutical products. The course will be of interest to managers and executives from the pharmaceutical industry, API manufacturers as well as distributors and traders.


EU Legislation on Distribution of APIs

  • Directive 2110/83/EC and 2011/62/EU (Falsified Medicines Directive): Which authorizations/registrations are required? Supervisions and sanctions
  • EU GDP Guideline for APIs (Overview)
  • EU GMP Guideline Part II
  • Annex 15
  • Annex 16
Quality System Elements for API Distributors
  • Manufacture, Importation, Distribution – what does your company do?
  • Elements of the Quality System for API Distributors
  • Technical Standards for Distribution of API
Application of Risk Management Principles in Planning and Surveillance of the API Distribution
  • Responsibilities, INCOTERMS, QA-Agreements
  • Key elements in planning and monitoring distribution routes
  • Risk-based qualification of distribution routes/ risk mitigation activities
GDP and the role of agents and traders within the supply chain
  • Types of intermediates
  • Key points of an agent’s quality system
  • Communication and exchange of information with the pharmaceutical manufacturer
  • Traceability of APIs and how to document it according to the new GDP guidelines
  • Key aspects of quality agreements
Conducting GDP audits at API suppliers’ sites – key points to be considered
  • Preparing a GDP audit
  • Key factors of success
  • GDP audits at suppliers’ sites in Far East – what has to be considered?
  • Frequent findings in audits
Implementation of GDP at an API manufacturer’s site – case study

Authority’s expectations and other API GDP topics
  • Hot spots from EU GDP Guideline for APIs
  • Outsourcing of GDP activities
  • API import: Written Confirmation
  • QP Declaration
  • GDP necessary or not?
„Risk Analysis of Transportation Routes – Practical Exercise“

In this workshop participants will work on specific cases regarding transportation of APIs by performing risk assessments for different scenarios.


This course is part of the GMP Certification Programme "ECA Certified GDP Compliance Manager" Learn more

This training/webinar cannot be booked. Send us your inquiry by using the following contact form.

To find alternative dates for this training/webinar or similar events please see the complete list of all events.

For many training courses and webinars, there are also recordings you can order and watch any time. Just take a look at the complete list of all recordings.

* also payable by credit card
American Express Visa Mastercard

Further dates on-site
Further dates on-site
Not available
Further dates online
Further dates online
Not available
Not available

Do you have any questions?

Please contact us:
Tel.: +49 6221 8444-0

Woman with headset

Go back

Testimonials about our courses and conferences

“Fantastic course – I really enjoyed the interactive structure & greatly appreciate social activity.”

Anthony Cummins, Sebela Pharmaceuticals, Ireland
GMP Auditor Practice, September 2023


“Very well organized, information on point without being overwhelming.”

Eleni Kallinikou, Pharmathen
Live Online Trainng - Pharmaceutical Contracts - Febuary 2024


“Good overview of different types of agreements, good to see both the GMP and the legal angle”

Ann Michiels, Johnson&Johnson
Live Online Trainng - Pharmaceutical Contracts, Febuary 2024



“Well prepared presentations and good presenters. I also like the way of asking questions.”

Alexandra Weidler, Hookipa Biotech GmbH, Austria
Live Online Training – QP Education Course Module A, November 2023